Copyright
©The Author(s) 2025.
World J Gastroenterol. Aug 14, 2025; 31(30): 109465
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.109465
Published online Aug 14, 2025. doi: 10.3748/wjg.v31.i30.109465
Table 2 Signet ring cell carcinoma rates according to the early-stage gastric cancer subgroup
| EGC subgroup | Number | SRCC rates (%) (mean) | SD |
| A1: Ulcer (-), size ≤ 2 cm | 317 | 74.0379 | 29.5714 |
| A2: Ulcer (-), 2 cm < size ≤ 4 cm | 157 | 72.8344 | 26.568 |
| A3: Ulcer (-), size > 4 cm | 43 | 69.3023 | 28.3175 |
| B1: Ulcer (+), size ≤ 2 cm | 56 | 67.3214 | 29.7102 |
| B2: Ulcer (+), 2 cm < size ≤ 4 cm | 56 | 60.3571 | 31.0989 |
| B3: Ulcer (+), size > 4 cm | 21 | 60 | 32.4808 |
- Citation: Kim C, Lee HS, Na HY, Kwon HJ, Lee JA, Suh YS, Kang SH, Kim HH, Ahn SH, Oh HJ. Prognostic value of signet-ring cell carcinoma proportion in undifferentiated gastric cancer: Implications for endoscopic treatment decisions. World J Gastroenterol 2025; 31(30): 109465
- URL: https://www.wjgnet.com/1007-9327/full/v31/i30/109465.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i30.109465